Bio-Techne (TECH) Assets Average (2010 - 2026)
Bio-Techne's (TECH) quarterly Assets Average came in at $2.5 billion in Q1 2026, down 4.54% year-on-year from $2.7 billion in Q1 2025, and little changed quarter-over-quarter from $2.5 billion in Q4 2025.
Bio-Techne (TECH) Assets Average (2010 - 2026) Analysis & Trends
Bio-Techne's Assets Average history runs 17 years deep, the most recent figure standing at $2.5 billion for Q1 2026.
- On a quarterly basis, Assets Average fell 4.54% year-over-year to $2.5 billion in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 4.54% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 1.51% from the prior year.
- Assets Average steadied at $2.5 billion in Q1 2026 per TECH's latest filing, from $2.5 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.7 billion in Q4 2023 and bottomed at $2.3 billion in Q2 2022.
- The 5-year median for Assets Average is $2.6 billion (2025), against an average of $2.6 billion.
- Across the five-year window, Assets Average gained 16.38% in 2023 and dropped 6.61% in 2025, its largest moves.
- Year by year, Assets Average stood at $2.4 billion in 2022, then climbed by 16.38% to $2.7 billion in 2023, then decreased by 1.45% to $2.7 billion in 2024, then slipped by 6.61% to $2.5 billion in 2025, then gained by 0.48% to $2.5 billion in 2026.
- Per Business Quant, the three latest TECH Assets Average figures stand at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 2.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54 Bn |
| Dec 31, 2025 | 2.52 Bn |
| Sep 30, 2025 | 2.54 Bn |
| Jun 30, 2025 | 2.60 Bn |
| Mar 31, 2025 | 2.66 Bn |
| Dec 31, 2024 | 2.70 Bn |
| Sep 30, 2024 | 2.72 Bn |
| Jun 30, 2024 | 2.71 Bn |
| Mar 31, 2024 | 2.73 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2023 | 2.70 Bn |
| Jun 30, 2023 | 2.62 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.32 Bn |
| Jun 30, 2022 | 2.30 Bn |
| Mar 31, 2022 | 2.30 Bn |
| Dec 31, 2021 | 2.29 Bn |
| Sep 30, 2021 | 2.27 Bn |
| Jun 30, 2021 | 2.17 Bn |